A Polymorphism in the TC21 Promoter Associates With an Unfavorable Tamoxifen Treatment Outcome in Breast Cancer
Cancer Research - United States
doi 10.1158/0008-5472.can-08-0247
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2008
Authors
Publisher
American Association for Cancer Research (AACR)